Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice

Psychoneuroendocrinology

Volumn 38, Issue 4, 2013, Pages 542-551

  Frau, Roberto ^a   Pillolla, Giuliano ^a   Bini, Valentina ^a   Tambaro, Simone ^b   Devoto, Paola ^a   Bortolato, Marco ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

5 reductase; D1 like receptors; D2 like receptors; Dopamine; Finasteride; Prepulse inhibition of the startle

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; FINASTERIDE; QUINPIROLE; STEROID 5ALPHA REDUCTASE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; ENZYME INHIBITION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PHARMACOLOGICAL BLOCKING; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX; STEREOTYPY;

5-ALPHA REDUCTASE INHIBITORS; ANIMALS; APOMORPHINE; BENZAZEPINES; CATALEPSY; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FINASTERIDE; HALOPERIDOL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; QUINPIROLE; SENSORY GATING; STEREOTYPED BEHAVIOR;

EID: 84875052255     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.07.014     Document Type: Article

References (71)

1. 1-like agonists in rats. J. Neurosci. 1996, 16:4823-4834.
2. Bardin L., Kleven M.S., Barret-Grévoz C., Depoortère R., Newman-Tancredi A. Neuropsychopharmacology 2006, 31:1869-1879.
3. Baulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998, 23:963-987.
4. Benus R.F., Bohus B., Koolhaas J.M., van Oortmerssen G.A. Behavioural differences between artificially selected aggressive and non-aggressive mice: response to apomorphine. Behav. Brain Res. 1991, 43:203-208.
5. Bini V., Frau R., Collu M., Paba S., Devoto P., Marrosu F., Bortolato M. Blockade of 5-alpha reductase reduces compulsive behaviors in mice. Proceedings of the 22nd ECNP Congress 2009.
6. 2 dopamine agonists in intact rats. Brain Res. 1989, 504:276-283.
7. 2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle. Neuropsychopharmacology 2005, 30:561-574.
8. Bortolato M., Muroni A., Marrosu F. Treatment of Tourette's syndrome with finasteride. Am. J. Psychiatry 2007, 164:1914-1915.
9. Bortolato M., Frau R., Orrù M., Bourov Y., Marrosu F., Mereu G., Devoto P., Gessa G.L. Antipsychotic-like properties of 5-alpha-reductase inhibitors. Neuropsychopharmacology 2008, 33:3146-3156.
10. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 1990, 47:181-188.
11. Braff D.L., Geyer M.A., Light G.A., Sprock J., Perry W., Cadenhead K.S., Swerdlow N.R. Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr. Res. 2001, 49:171-178.
12. 2 receptor interaction in the generation of dopamine agonist related behaviors. Eur. J. Pharmacol. 1986, 131:301-306.
13. Byrnes E.M., Bridges R.S., Scanlan V.F., Babb J.A., Byrnes J.J. Sensorimotor gating and dopamine function in postpartum rats. Neuropsychopharmacology 2007, 32:1021-1031.
14. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol. Psychiatry 1996, 39:33-41.
15. 5 dopamine receptors in motor activity and striatal synaptic plasticity. J. Neurosci. 2003, 23:8506-8512.
16. Chappell P., Riddle M., Anderson G., Scahill L., Hardin M., Walker D., Cohen D., Leckman J. Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture. Biol. Psychiatry. 1994, 36:35-43.
17. Corbett B.A., Mendoza S.P., Baym C.L., Bunge S.A., Levine S. Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome. Psychoneuroendocrinology 2008, 33:810-820.
18. Davis M., Commissaris R.L., Cassella J.V., Yang S., Dember L., Harty T.P. Differential effects of dopamine agonists on acoustically and electrically elicited startle responses: comparison to effects of strychnine. Brain Res. 1986, 371:58-69.
19. Devoto, P., Frau, R., Bini, V., Pillolla, G., Saba, P., Flore, G., Corona, M., Marrosu, F., Bortolato, M. Inhibition of 5alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation. Psychoneuroendocrinology, , in press. doi:10.1016/j.psyneuen.2011.09.018.
20. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev. Neurosci. 1994, 5:27-41.
21. 3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice. Neuropsychopharmacology 2008, 33:2648-2656.
22. 1 and sigma-1 receptor. Neuropharmacology 2007, 52:966-974.
23. Do Rego J.L., Seong J.Y., Burel D., Leprince J., Vaudry D., Luu-The V., Tonon M.C., Tsutsui K., Pelletier G., Vaudry H. Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides. Front. Endocrinol. 2012, 3:4.
24. Dubrovsky B. Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol. Biochem. Behav. 2006, 84:644-655.
25. 2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J. Neurosci. 2011, 31:7349-7356.
26. Eser D., Baghai T.C., Schüle C., Nothdurfter C., Rupprecht R. Neuroactive steroids as endogenous modulators of anxiety. Curr. Pharm. Des. 2008, 14:3525-3533.
27. Frye C.A., Walf A.A. Infusions of anti-sense oligonucleotides for DARPP-32 to the ventral tegmental area reduce effects of progesterone- and a dopamine type 1-like receptor agonist to facilitate lordosis. Behav. Brain Res. 2010, 206:286-292.
28. 1 receptor signaling at presynaptic sites in the prelimbic cortex. Biochim. Biophys. Acta 2010, 1803:1396-1408.
29. 2 receptor agonists. J. Pharmacol. Exp. Ther. 1997, 283:7-15.
30. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001, 156:117-154.
31. Groenewegen H.J., Trimble M. The ventral striatum as an interface between the limbic and motor systems. CNS Spectr. 2007, 12:887-892.
32. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003, (Suppl. 2):17-54.
33. 2-like agonist effects on motor activity of C57 mice: differences compared to rats. Synapse 1997, 26:81-92.
34. 2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia. Psychopharmacology 1994, 115:447-453.
35. 5 receptor null mutant mice. Behav. Neurosci. 2001, 115:1129-1144.
36. Kalueff A.V., Jensen C.L., Murphy DL Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Res. 2007, 1169:87-97.
37. Kelly S.J., Ostrowski N.L., Wilson M.A. Gender differences in brain and behavior: hormonal and neural bases. Pharmacol. Biochem. Behav. 1999, 64:655-664.
38. Kinney G.G., Wilkinson L.O., Saywell K.L., Tricklebank M.D. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J. Neurosci. 1999, 19:5644-5653.
39. Koethe D., Bortolato M., Piomelli D., Leweke F.M. Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report. Pharmacopsychiatry 2008, 41:115-116.
40. 2 synergism and its breakdown. Brain Res. 1996, 728:97-104.
41. Mani S.K., Fienberg A.A., O'Callaghan J.P., Snyder G.L., Allen P.B., Dash P.K., Moore A.N., Mitchell A.J., Bibb J., Greengard P., O'Malley B.W. Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice. Science 2000, 287:1053-1056.
42. 2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats. Psychopharmacology 2000, 151:38-48.
43. Martini L., Melcangi R.C., Maggi R. Androgen and progesterone metabolism in the central and peripheral nervous system. J. Steroid Biochem. Mol. Biol. 1993, 47:195-205.
44. Martini L., Celotti F., Melcangi R.C. Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved. Cell. Mol. Neurobiol. 1996, 16:271-282.
45. Muroni A., Paba S., Puligheddu M., Marrosu F., Bortolato M. A preliminary study of finasteride in Tourette syndrome. Mov. Disord. 2011, 26:2146-2147.
46. Myin-Germeys I., Krabbendam L., Jolles J., Delespaul P.A., van Os J. Are cognitive impairments associated with sensitivity to stress in schizophrenia? An experience sampling study. Am. J. Psychiatry. 2002, 159:443-449.
47. 1 receptor-mediated effects of cocaine. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18676-18681.
48. Paba S., Frau R., Godar S.C., Devoto P., Marrosu F., Bortolato M. Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders. Curr. Pharm. Des. 2011, 17:151-167.
49. Phan V.L., Urani A., Romieu P., Maurice T. Strain differences in sigma(1) receptor-mediated behaviours are related to neurosteroid levels. Eur. J. Neurosci. 2002, 15:1523-1534.
50. Petralia S.M., Frye C.A. In the ventral tegmental area, G-proteins mediate progesterone's actions at dopamine type 1 receptors for lordosis of rats and hamsters. Psychopharmacology (Berl.) 2006, 186:133-142.
51. 2 receptors regulating rat locomotor activity. Psychopharmacology (Berl.) 1989, 99:558-562.
52. 2 receptor antagonists. J. Neurosci. 2001, 21:305-313.
53. 2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. J. Pharmacol. Exp. Ther. 2005, 312:733-741.
54. 2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice. Psychopharmacology 2007, 191:731-739.
55. 2 receptor knock-out mice. J. Neurosci. 2002, 22:9604-9611.
56. 2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 2003, 28:108-118.
57. Romanelli R.J., Williams J.T., Neve K.A. Dopamine receptor signaling: intracellular pathways to behavior. The Dopamine Receptors 2010, 137-173. Humana, Totawa. 2nd ed. K.A. Neve (Ed.).
58. Rupprecht R., Holsboer F. Neuroactive steroids in neuropsychopharmacology. Int. Rev. Neurobiol. 2001, 46:461-477.
59. Sánchez M.G., Bourque M., Morissette M., Di Paolo T. Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci. Ther. 2010, 16:e43-e71.
60. Santangelo S.L., Pauls D.L., Goldstein J.M., Faraone S.V., Tsuang M.T., Leckman J.F. Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder?. J. Am. Acad. Child Adolesc. Psychiatry 1994, 33:795-804.
61. Swerdlow N.R., Martinez Z.A., Hanlon F.M., Platten A., Farid M., Auerbach P., Braff D.L., Geyer M.A. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J. Neurosci. 2000, 20:4325-4336.
62. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl.) 2001, 156:194-215.
63. 2 blockade. Pharmacol. Biochem. Behav. 2005, 82:293-299.
64. Thigpen A.E., Russell D.W. Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor. J. Biol. Chem. 1992, 267:8577-8583.
65. Voorn P., Vanderschuren L.J., Groenewegen H.J., Robbins T.W., Pennartz C.M. Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci. 2004, 8:468-474.
66. Wan F.J., Swerdlow N.R. Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology 1993, 113:103-109.
67. 2 interactions regulate prepulse inhibition in rats?. Neuropsychopharmacology 1996, 14:265-274.
68. 2 interactions by muscarinic receptors. J. Pharmacol. Exp. Ther. 1997, 281:972-982.
69. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.
70. Zhang J., Forkstam C., Engel J.A., Svensson L. Role of dopamine in prepulse inhibition of acoustic startle. Psychopharmacology (Berl) 2000, 149:181-188.
71. Zinder O., Dar D.E. Neuroactive steroids: their mechanism of action and their function in the stress response. Acta Physiol. Scand. 1999, 167:181-188.